REQUEST A DEMO
Total
USD $0.00
Search more companies

Biosintez PAO (Russia)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Biosintez PAO Profile Updated: July 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Russian Download a sample report

"Biosintez" is one of the eldest enterprises of pharmaceutical industry in Russia. The Penza plant of medical preparations was established in 1959. Production of antibiotic substances by fermentation was chosen as a main direction of its activity, and antibiotic biomycin (chlortetracycline) and vitamin B12 were the first products. Later other antibiotic substances were included into product list: oleandomycin, tetracycline, nystatin, heliomycin (Gold medal of Exhibition of Achievements of National Economy in 1970), fusidic acid and sodium fusidate, levorin (candicidin), benzylpenicillin potassium, mycoheptin, as well as cardiovascular riboxin (inosin). Besides the substances, as early as in 1961 the Plant began to produce the formulated preparations, tablets, in 1971 manufactures of infusions and filling of powders for injection were put into operation. Also production of endocrine preparations was organized, in 1986 - insulin, in 1989 - heparin.

Headquarters
Ulitsa Druzhby, Dom 4
Penza; Penza Oblast; Postal Code: 440013

Contact Details: Purchase the Biosintez PAO report to view the information.

Website: http://biosintez.com/

Basic Information
Total Employees:
Purchase the Biosintez PAO report to view the information.
Outstanding Shares:
Purchase the Biosintez PAO report to view the information.
Registered Capital:
Purchase the Biosintez PAO report to view the information.
Financial Auditors:
Purchase the Biosintez PAO report to view the information.
Incorporation Date:
November 26, 1992
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
96.96%
Subsidiaries
Penzenskaya Exportno-Importnaya Kompaniya OOO
10%
Penzenskii Gubernskii Delovoi Center OOO
9.0909%
Smo Vita OOO
1.2181%
Company Performance
Financial values in the chart are available after Biosintez PAO report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
28.28%
Total operating revenue
28.28%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
N/A
Total assets
-3.11%
Total equity
19.76%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-29.13%
Quick Ratio
-1.37%
Cash Ratio
-0.09%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?